Circ_0035796 depletion inhibits transforming growth factor-β1-induced pulmonary fibrosis in a miR-150-5p/L1CAM-dependent manner

References

• Meyer KC. Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis. Expert Rev Respir Med. 2017;11(5):1–10.
   PubMed Web of Science ®Google Scholar
• Savin IA, Zenkova MA, Sen’kova AV. Pulmonary fibrosis as a result of acute lung inflammation: molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches. Int J Mol Sci. 2022;23:14959.
   PubMedGoogle Scholar
• Zhang J-X, Lu J, Xie H, et al. circHIPK3 regulates lung fibroblast-to-myofibroblast transition by functioning as a competing endogenous RNA. Cell Death Dis. 2019;10(3):182–182.
   PubMedGoogle Scholar
• Kinoshita T, Goto T. Molecular mechanisms of pulmonary fibrogenesis and its progression to lung cancer: a review. Int J Mol Sci. 2019;20:1461.
   PubMedGoogle Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
   PubMed Web of Science ®Google Scholar
• Chen Z, Song M, Wang T, et al. Role of circRNA in E3 modification under human disease. Biomolecules. 2022;12:1320.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang T, Xiao J. Circular RNAs: promising biomarkers for human diseases. EBioMedicine. 2018;34:267–274.
   PubMed Web of Science ®Google Scholar
• Li C, Wang Z, Zhang J, et al. Crosstalk of mRNA, miRNA, lncRNA, and circRNA and their regulatory pattern in pulmonary fibrosis. Mol Ther Nucleic Acids. 2019;18:204–218.
   PubMedGoogle Scholar
• Xu Q, Cheng D, Li G, et al. CircHIPK3 regulates pulmonary fibrosis by facilitating glycolysis in miR-30a-3p/FOXK2-dependent manner. Int J Biol Sci. 2021;17(9):2294–2307.
   PubMed Web of Science ®Google Scholar
• Qi F, Li Y, Yang X, et al. Hsa_circ_0044226 knockdown attenuates progression of pulmonary fibrosis by inhibiting CDC27. Aging. 2020;12(14):14808–14818.
   PubMedGoogle Scholar
• Li R, Wang Y, Song X, et al. Potential regulatory role of circular RNA in idiopathic pulmonary fibrosis. Int J Mol Med. 2018;42(6):3256–3268.
   PubMed Web of Science ®Google Scholar
• Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Disease Models & Mechanisms. 2021;14:dmm047662.
   PubMed Web of Science ®Google Scholar
• Climent M, Viggiani G, Chen YW, et al. MicroRNA and ROS crosstalk in cardiac and pulmonary diseases. Int J Mol Sci. 2020;21:4370.
   PubMed Web of Science ®Google Scholar
• Çakmak HA, Demir M. MicroRNA and cardiovascular diseases. Balkan Med J. 2020;37(2):60–71.
   PubMed Web of Science ®Google Scholar
• Mo Y, Zhang Y, Wan R, et al. miR-21 mediates nickel nanoparticle-induced pulmonary injury and fibrosis. Nanotoxicology. 2020;14(9):1175–1197.
   PubMed Web of Science ®Google Scholar
• Liu H, He Y, Jiang Z, et al. Prodigiosin alleviates pulmonary fibrosis through inhibiting miRNA-410 and TGF-β1/ADAMTS-1 signaling pathway. Cell Physiol Biochem. 2018;49(2):501–511.
   PubMedGoogle Scholar
• Keller A, Ludwig N, Fehlmann T, et al. Low miR-150-5p and miR-320b expression predicts reduced survival of COPD patients. Cells. 2019;8:1162.
   PubMed Web of Science ®Google Scholar
• Suetsugu T, Koshizuka K, Seki N, et al. Downregulation of matrix metalloproteinase 14 by the antitumor miRNA, miR-150-5p, inhibits the aggressiveness of lung squamous cell carcinoma cells. Int J Oncol. 2018;52:913–924.
   PubMed Web of Science ®Google Scholar
• Yang Y, Tai W, Lu N, et al. lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging (Albany NY). 2020;12(10):9085–9102.
   PubMedGoogle Scholar
• van Zonneveld AJ, Kölling M, Bijkerk R, et al. Circular RNAs in kidney disease and cancer. Nat Rev Nephrol. 2021;17(12):814–826.
   PubMed Web of Science ®Google Scholar
• Fang S, Guo H, Cheng Y, et al. circHECTD1 promotes the silica-induced pulmonary endothelial-mesenchymal transition via HECTD1. Cell Death Dis. 2018;9(3):396.
   PubMedGoogle Scholar
• Wu Q, Jiao B, Zhang Q, et al. Identification of circRNA expression profiles and the potential role of hsa_circ_0006916 in silicosis and pulmonary fibrosis. Toxicology. 2023;483:153384.
   PubMed Web of Science ®Google Scholar
• Cheng Z, Zhang Y, Wu S, et al. Peripheral blood circular RNA hsa_circ_0058493 as a potential novel biomarker for silicosis and idiopathic pulmonary fibrosis. Ecotoxicol Environ Saf. 2022;236:113451.
   PubMed Web of Science ®Google Scholar
• Parimon T, Hohmann MS, Yao C. Cellular senescence: pathogenic mechanisms in lung fibrosis. Int J Mol Sci. 2021;22:6214.
   PubMed Web of Science ®Google Scholar
• Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol. 2014;5:123–123.
   PubMed Web of Science ®Google Scholar
• Nho RS, Ballinger MN, Rojas MM, et al. Biomechanical force and cellular stiffness in lung fibrosis. Am J Pathol. 2022;192(5):750–761.
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang H, Niu Y, et al. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Mol Cancer. 2017;16(1):118.
   PubMedGoogle Scholar
• Hua T, Liu S, Xin X, et al. Prognostic significance of L1 cell adhesion molecule in cancer patients: a systematic review and meta-analysis. Oncotarget. 2016;7(51):85196–85207.
   PubMedGoogle Scholar
• Kiefel H, Bondong S, Hazin J, et al. L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr. 2012;6(4):374–384.
   PubMed Web of Science ®Google Scholar
• Brümmendorf T, Kenwrick S, Rathjen FG. Neural cell recognition molecule L1: from cell biology to human hereditary brain malformations. Curr Opin Neurobiol. 1998;8(1):87–97.
   PubMed Web of Science ®Google Scholar
• Herron LR, Hill M, Davey F, et al. The intracellular interactions of the L1 family of cell adhesion molecules. Biochem J. 2009;419(3):519–531.
   PubMedGoogle Scholar
• Liu X, Min S, Wu N, et al. miR-193a-3p inhibition of the slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/slug/L1CAM pathway. Cancer Lett. 2019;447:56–65.
   PubMed Web of Science ®Google Scholar
• Li J, Jiang ZZ, Li YY, et al. LncRNA CHRF promotes TGF-β1 induced EMT in alveolar epithelial cells by inhibiting miR-146a up-regulating L1CAM expression. Exp Lung Res. 2021;47(4):198–209.
   PubMed Web of Science ®Google Scholar
• Hauser S, Bickel L, Weinspach D, et al. Full-length L1CAM and not its Δ2Δ27 splice variant promotes metastasis through induction of gelatinase expression. PLoS One. 2011;6(4):e18989.
   PubMed Web of Science ®Google Scholar